Andy Corley Yelroc Consulting Inc.

Andy Corley
Yelroc Consulting Inc.

Co-founded eyeonics, Inc
◦ Developed new category of intraocular lens, the
accommodating IOL, known as Crystalens
◦ Sold to Bausch + Lomb in 2008, served as President of
the Surgical Division

Co-founder of Chiron Ophthalmics
◦ General Manager of the Refractive Surgery Division
◦ Played a key role in the introduction of LASIK



2005 Orange County Entrepreneur of the Year
Crystalens 2005 AeA Technology of the Year
Graduate of Georgia Southern University


Owner, Yelroc Consulting Inc.
Senior Consultant to Bausch + Lomb
◦ Was Chairman of the Board of Technolas Perfect Vision,
recently purchased by B+L



Executive Chairman of NeoVista Inc.
Venture Partner at One Focus Ventures
Advisory boards:
◦ UCI School of Biomedical Engineering
◦ Scripps Genomic Institute
The Only Global Company Focused
Solely On Eye Health
CONFIDENTIAL
[4]
Rich Heritage
Manufactures world’s
first approved
soft contact lens
John Jacob
Bausch opens an
optical goods shop
in Rochester, N.Y.
Lotemax
ophthalmic
steroid
launched
Develop
PureVision
SiHy
contact lens
First optical quality
glass produced in
America
Microscope,
binocular and
telescope
production begins
Ray-Ban
sunglass
line
introduced
ReNu all-in-one
contact lens
cleaning solution
introduced
Acquire Dr. Mann
Pharma and
Pharmafair, Inc. to
form pharma business
segment
1853
1870
–
1900
1910s
1930s
1893
1970s
1980s
Acquisitions of
Groupe Chauvin,
CT Freda,
eyeonics and
Tubilux expand Besivance
pharma and
antbacterial
surgical portfolios
launched
Establish
present
business model
via
acquisition of
surgical
product lines
and divestiture
of sunglass and
other non-core
business lines
1990s
Divest
refractive
surgery
business thru
formation of
joint venture
with 2010
Perfect Vision
BioTrue
multipurpose
solution
launched
Crystalens AO
launched for
PureVision2HD
cataract
contact lenses
patients
launched
2000s
2008
[5]
Global Reach and Perspective
Revenues in
100+ Countries
~11,000 Global
Employees
Manufacturing
in 9 Countries
6 Major Global
D&R Sites
[6]
Key Macro Trends Fueling Demand for Eye Health Services
Aging
population
65+ age group (~630 MM) expected to double by 2030 (~1.2 Bn)1
Type 2
Diabetes
Number of cases doubled over last 30 years2; increasing prevalence
Expanding
Middle Class
Increasing demand & willingness to pay for eye health services
Emerging
markets
Contributing up to ~50% of global GDP growth through the decade3
Heightened
innovation
Comfort, safety and efficacy enhanced through technology
Eye health is resilient to economic and legislative factors
1
Source: United Nations Population Division World Population Prospects, 2010 Revision
Source: USA Today, “Diabetes on the Upswing”, 6/25/2011
3 Source: World Market Monitor
2
[7]
Solely Focused on Eye Health
PHARMA
VISION
CARE
Customers+ Patients
SURGICAL
Internal and External
Pipeline Growth
Geographic
Expansion
Brand
and Scale
Focus on
Execution
[8]
Broad Product Portfolio
Vision Care
Pharmaceutical
Surgical
Multipurpose
Solutions
Ocular Vitamin
Intraocular Lenses (IOLs)
Antibiotic
Antiviral
Dry Eye
Contact Lenses
Cosmetic Contact Lenses
Anti-inflammatory
Surgical Equipment
[9]
Surgical
Serving the Needs of Ophthalmic Surgeons Worldwide
Cataract
Retinal
Refractive
[ 10 ]
Cataract Surgery
Most Commonly Performed Surgery in the World
Akreos® IOLs
Intraocular Lenses (IOLs)
Viscoelastics
Surgical Instruments/Packs
Surgical Equipment
[ 11 ]
Retinal Surgery
Treating eye problems of the
retina, macula, and vitreous fluid
Surgical Equipment
Surgical Instruments
[ 12 ]
Refractive Surgery
Performed to decrease or
eliminate dependency on glasses or contact lenses
TECHNOLAS® Excimer Workstation
ZYOPTIX® Diagnostic Workstation
Surgical Equipment
Surgical Instruments
[ 13 ]